Researchers from HMRI’s Drug Repurposing Research Program are currently waging a two-pronged attack on ovarian cancer. Dr Michelle Wong-Brown says that their research started out trying to find new drugs for treatment-resistant ovarian cancer. A lot of ovarian cancers are detected late and subsequently recur because they have metastasised, meaning that these patients get bombarded […]
Category: Drug Repurposing and Medicines
Exploring new treatment opportunities for ovarian cancer
Drug repurposing involves investigating new uses for approved drugs that could be used to treat other conditions in a timely, costly and hugely impactful way. Professor Nikola Bowden and Jill Emberson PhD Scholarship Winner, Bayley Matthews, spoke with ABC Newcastle about their research into repurposing drugs to find a treatment for ovarian cancer.
Researchers discover potential new melanoma treatment giving hope to patients
HMRI and University of Newcastle researchers have discovered that treating patients who have late-stage treatment resistant melanoma with a combination of two existing drugs significantly increases their survival times.
One year into the Jill Emberson PhD Scholarship: discovering new treatment options and improving outcomes
It’s been almost a year since Bayley Mathews was awarded the Jill Emberson Pink meets Teal PhD Scholarship. On Teal Ribbon Day, Bayley reflects on the first year of his three-year scholarship
